This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Industry-University Cooperation Foundation Hanyang University. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations in Keloid Treatment by Won Jai Lee
Introduction
Won Jai Lee is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of keloid and hypertrophic scars. His innovative approach focuses on targeting specific molecular interactions to improve treatment outcomes.
Latest Patents
Won Jai Lee holds a patent for a composition aimed at preventing or treating keloid disease or scars. The patent describes a pharmaceutical composition that inhibits mortalin expression and its interaction with p53, which are identified as new targets for keloid treatment. The invention demonstrates that by preparing a mortalin-specific shRNA and injecting it into a keloid spheroid, apoptosis and an anti-fibrotic effect can be achieved. This method effectively reduces ECM expression and induces apoptosis, making mortalin knockdown a promising strategy for keloid treatment. He has 1 patent to his name.
Career Highlights
Won Jai Lee is affiliated with the Industry-University Cooperation Foundation at Hanyang University. His work in this institution has allowed him to collaborate with other researchers and contribute to advancements in medical treatments.
Collaborations
One of his notable collaborators is Chae Ok Yun. Their partnership has likely facilitated the development of innovative solutions in the field of scar treatment.
Conclusion
Won Jai Lee's contributions to the treatment of keloid scars through innovative pharmaceutical compositions highlight the importance of targeted molecular therapies. His work continues to pave the way for advancements in medical science.